Logo image of NEUE

NEUEHEALTH INC (NEUE) Stock Analyst Earnings Estimates

NYSE:NEUE - New York Stock Exchange, Inc. - US10920V4041 - Common Stock - Currency: USD

6.7748  +0 (+0.07%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026
Revenue
YoY % growth
NEUE revenue by date.NEUE revenue by date.
2.412B
59.42%
1.161B
-51.87%
937M
-19.28%
1.255B
33.94%
1.329B
5.90%
EBITDA
YoY % growth
NEUE ebitda by date.NEUE ebitda by date.
-424.4M
-38.69%
-145M
65.83%
-78M
46.21%
50.298M
164.48%
64.267M
27.77%
EBIT
YoY % growth
NEUE ebit by date.NEUE ebit by date.
-475M
-39.09%
-169M
64.42%
-94M
44.38%
-54.366M
42.16%
-39.984M
26.45%
Operating Margin
NEUE operating margin by date.NEUE operating margin by date.
-19.69%-14.56%-10.03%-4.33%-3.01%
EPS
YoY % growth
NEUE eps by date.NEUE eps by date.
-128.80
-11.32%
-6.86
94.67%
-19.76
-188.05%
-16.99
14.00%
-14.90
12.30%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-4.39
39.67%
-3.72
5.03%
-4.62
-348.60%
Revenue
Q2Q % growth
300.81M
33.11%
307.35M
31.95%
324.84M
39.63%
EBITDA
Q2Q % growth
11.74M
167.24%
16.368M
427.36%
13.041M
218.13%
EBIT
Q2Q % growth
-14.484M
44.29%
-9.792M
42.40%
-16.422M
39.27%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
0.47
106.23%
-4.264.73111.02%
Q4 2024
Q2Q % growth
-1.03
-105.14%
-4.073.0474.72%
Q3 2024
Q2Q % growth
-3.92
54.04%
-3.16-0.76-23.97%
Q2 2024
Q2Q % growth
-7.27
-82.66%
-3.33-3.94-118.63%
Q1 2024
Q2Q % growth
-7.54
47.64%
-5.41-2.13-39.47%
Q4 2023
Q2Q % growth
20.05
173.71%
-4.2424.29572.52%
Q3 2023
Q2Q % growth
-8.53
78.68%
-4.45-4.08-91.81%
Q2 2023
Q2Q % growth
-3.98
88.94%
-5.551.5728.34%
Q1 2023
Q2Q % growth
-14.40
43.75%
-7.75-6.65-85.76%
Q4 2022
Q2Q % growth
-27.20
-2,008.53%
-41.6214.4234.64%
Q3 2022
Q2Q % growth
-40.00
-8,233.33%
-29.70-10.30-34.67%
Q2 2022
Q2Q % growth
-36.00
-12,757.14%
-26.30-9.70-36.87%
Q1 2022
Q2Q % growth
-25.60 -19.73-5.87-29.76%
Q4 2021
Q2Q % growth
-1.29 -0.46-0.83-181.40%
Q3 2021
Q2Q % growth
-0.48 -0.15-0.33-226.05%
Q2 2021
Q2Q % growth
-0.28 -0.16-0.12-71.80%
NEUE Yearly EPS VS EstimatesNEUE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -50 -100
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
215.787M
-11.96%
322.32M-106.533M-33.05%
Q4 2024
Q2Q % growth
232.638M
-20.57%
256.97M-24.332M-9.47%
Q3 2024
Q2Q % growth
232.933M
-13.54%
239.58M-6.647M-2.77%
Q2 2024
Q2Q % growth
225.991M
-69.77%
257.53M-31.539M-12.25%
Q1 2024
Q2Q % growth
245.095M
-67.59%
253.48M-8.385M-3.31%
Q4 2023
Q2Q % growth
292.871M
-84.49%
289.11M3.761M1.30%
Q3 2023
Q2Q % growth
269.399M
39.30%
290.1M-20.701M-7.14%
Q2 2023
Q2Q % growth
747.68M
400.79%
767.09M-19.41M-2.53%
Q1 2023
Q2Q % growth
756.341M
318.33%
787.96M-31.619M-4.01%
Q4 2022
Q2Q % growth
1.889B
221.53%
1.764B124.6M7.06%
Q3 2022
Q2Q % growth
193.4M
-82.07%
1.802B-1.609B-89.27%
Q2 2022
Q2Q % growth
149.3M
-86.60%
1.849B-1.7B-91.93%
Q1 2022
Q2Q % growth
180.8M
-79.33%
1.78B-1.599B-89.84%
Q4 2021
Q2Q % growth
-1.554B
-367.09%
1.102B-2.656B-241.02%
Q3 2021
Q2Q % growth
1.079B
206.36%
1.106B-27.3M-2.47%
Q2 2021
Q2Q % growth
1.114B
275.14%
1.059B54.8M5.17%
Q1 2021
Q2Q % growth
874.6M
340.38%
%
NEUE Yearly Revenue VS EstimatesNEUE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2B 4B 6B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0% 0%
Revenue0% 0% 0% 0%